What is Zacks Research's Estimate for EverQuote Q2 Earnings?

Key Points

• Zacks Research cut its Q2 2026 EPS estimate to $0.40 (from $0.42) and rates EverQuote a "Hold," while the consensus full-year EPS is $0.72 and Zacks provided multi-year forecasts including FY2028 EPS of $2.40.
• EverQuote last reported $1.54 EPS and $195.3M revenue, easily beating estimates, with revenue up 32.3% year-over-year and a net margin of 14.34%.
• Analyst sentiment is mixed versus current trading — consensus target $23.83 vs. shares near $15.88 (PE ~6.0), and insiders have sold 34,456 shares (~$677k) in the past 90 days while owning 25.52% of the stock.

EverQuote, Inc. (NASDAQ:EVER - Free Report) - Analysts at Zacks Research cut their Q2 2026 earnings per share estimates for shares of EverQuote in a note issued to investors on Thursday, April 9th. Zacks Research analyst Team now forecasts that the company will post earnings of $0.40 per share for the quarter, down from their previous estimate of $0.42. Zacks Research has a "Hold" rating on the stock. The consensus estimate for EverQuote's current full-year earnings is $0.72 per share. Zacks Research also issued estimates for EverQuote's Q1 2027 earnings at $0.37 EPS, Q2 2027 earnings at $0.32 EPS, Q1 2028 earnings at $0.49 EPS and FY2028 earnings at $2.40 EPS.

EverQuote (NASDAQ:EVER - Get Free Report) last issued its quarterly earnings results on Monday, February 23rd. The company reported $1.54 earnings per share for the quarter, beating the consensus estimate of $0.35 by $1.19. The company had revenue of $195.32 million during the quarter, compared to the consensus estimate of $176.82 million. EverQuote had a return on equity of 57.65% and a net margin of 14.34%.EverQuote's revenue was up 32.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.33 EPS.

Other analysts also recently issued reports about the company. Wall Street Zen downgraded EverQuote from a "strong-buy" rating to a "buy" rating in a report on Saturday, April 4th. Canaccord Genuity Group dropped their price objective on EverQuote from $33.00 to $28.00 and set a "buy" rating for the company in a report on Tuesday, February 24th. Raymond James Financial restated an "outperform" rating and set a $18.00 price objective on shares of EverQuote in a report on Tuesday, February 17th. Craig Hallum restated a "buy" rating and set a $20.00 price objective on shares of EverQuote in a report on Tuesday, February 24th. Finally, Needham & Company LLC dropped their price objective on EverQuote from $40.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, February 24th. Six equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $23.83.

EverQuote Stock Performance

Shares of EVER opened at $15.88 on Friday. The stock has a fifty day moving average of $16.16 and a two-hundred day moving average of $21.51. The company has a market capitalization of $572.16 million, a PE ratio of 6.02 and a beta of 0.62. EverQuote has a fifty-two week low of $13.93 and a fifty-two week high of $28.73.

Insider Transactions at EverQuote

In other news, CEO Jayme Mendal sold 14,360 shares of the company's stock in a transaction on Friday, February 20th. The stock was sold at an average price of $14.98, for a total transaction of $215,112.80. Following the completion of the sale, the chief executive officer directly owned 541,777 shares in the company, valued at $8,115,819.46. This represents a 2.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director John L. Shields sold 2,000 shares of the company's stock in a transaction on Monday, January 12th. The stock was sold at an average price of $25.73, for a total transaction of $51,460.00. Following the sale, the director directly owned 25,219 shares of the company's stock, valued at approximately $648,884.87. This trade represents a 7.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 34,456 shares of company stock worth $677,348 in the last ninety days. Insiders own 25.52% of the company's stock.

Institutional Trading of EverQuote

Institutional investors have recently added to or reduced their stakes in the business. Comerica Bank boosted its position in EverQuote by 235.4% during the 3rd quarter. Comerica Bank now owns 1,100 shares of the company's stock worth $25,000 after purchasing an additional 772 shares during the period. Versant Capital Management Inc boosted its position in EverQuote by 108.9% during the 3rd quarter. Versant Capital Management Inc now owns 1,153 shares of the company's stock worth $26,000 after purchasing an additional 601 shares during the period. NewEdge Advisors LLC purchased a new stake in EverQuote during the 3rd quarter worth $52,000. Clearstead Advisors LLC boosted its position in EverQuote by 70.5% during the 4th quarter. Clearstead Advisors LLC now owns 1,997 shares of the company's stock worth $54,000 after purchasing an additional 826 shares during the period. Finally, Jones Financial Companies Lllp boosted its position in EverQuote by 595.8% during the 3rd quarter. Jones Financial Companies Lllp now owns 2,623 shares of the company's stock worth $62,000 after purchasing an additional 2,246 shares during the period. 91.54% of the stock is owned by hedge funds and other institutional investors.

About EverQuote

EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.

The company's core business centers on a quote-comparison engine for personal auto, home, and health insurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.